Results 281 to 290 of about 151,232 (337)

Management of von Willebrand Disease With a Factor VIII-Poor von Willebrand Factor Concentrate: Results From the Paediatric Cohort of a Prospective Observational Post-Marketing Study. [PDF]

Haemophilia
Goudemand J, Borel-Derlon A, Claeyssens S, Chambost H, Mourey G, Harroche A, Meunier S, Henriet C, Leroi T, Susen S, Repesse Y.   +10 more
europepmc   +1 more source

Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A. [PDF]

Haematologica
Gringeri A, Mannucci PM, Gringeri M, Castaman G, Peyvandi F.   +4 more
europepmc   +1 more source

A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants.

Blood
Hordijk S, Groten SA, Bürgisser PE, Laan SNJ, Korenke GC, Honzík T, Beysen D, Leebeek FWG, Skehel PA, van den Biggelaar M, Carter T, Bierings R.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

von Willebrand disease

Nature Reviews Disease Primers
von Willebrand disease (VWD) is the most common inherited bleeding disorder. The disorder is characterized by excessive mucocutaneous bleeding. The most common bleeding manifestations of this condition include nosebleeds, bruising, bleeding from minor wounds, menorrhagia or postpartum bleeding in women as well as bleeding after surgery.
O. Seidizadeh, J. Eikenboom, Cécile V Denis, Veronica H Flood, Paula James, P. Lenting, L. Baronciani, James S. O’Donnell, D. Lillicrap, F. Peyvandi   +9 more
semanticscholar   +3 more sources

Von Willebrand Disease

Maternal-Fetal Evidence Based Guidelines, 2022
Objective: To determine the clinical features and laboratory parameters of patients of von Willebrand disease (vWD) in our population. Study Design: Cross-sectional study.
Melody Safarzadeh
semanticscholar   +1 more source